Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains

J Clin Pharm Ther. 2007 Aug;32(4):403-8. doi: 10.1111/j.1365-2710.2007.00836.x.

Abstract

Background: Klebsiella pneumoniae belongs to important nosocomial pathogens causing mainly hospital-acquired infections. Beta-lactam antibiotics are frequently used in the treatment of infections caused by K. pneumoniae, but by their selection pressure the bacteria become resistant. Excessive use of third-generation cephalosporins is a risk factor for the occurrence and spread of ESBL-producing bacterial strains. The goal of this study was to describe the utilization of third-generation cephalosporins and to analyse their selection pressure on K. pneumoniae in the University Hospital in Olomouc.

Methods: Data on the utilization of antibiotics in the hospital were obtained for the period 1997-2005 from the computerized database and expressed in defined daily doses per 100 bed-days (DBD). The data were processed according to the ATC/DDD system. Klebsiella pneumoniae strains were isolated from clinical material obtained from hospitalized patients.

Results: Consumption of third-generation cephalosporins, which was 1.79 DBD in 1997, decreased to 0.93 in 1999, remained stable until 2002, and then increased to 2.40 DBD in 2005. During the 9-year period analysed, a total of 9564 strains of K. pneumoniae were isolated. The ESBL-positive K. pneumoniae strains frequency increased from 8% to 18%.

Conclusions: Increasing utilization of third-generation cephalosporins was associated with a statistically and clinically significant increased incidence of ESBL-positive K. pneumoniae strains.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cephalosporins / administration & dosage
  • Cephalosporins / therapeutic use*
  • Cross Infection / microbiology
  • Czech Republic
  • Databases, Factual
  • Drug Utilization Review
  • Hospitals, University
  • Humans
  • Klebsiella Infections / drug therapy*
  • Klebsiella Infections / microbiology
  • Klebsiella pneumoniae / drug effects*
  • Microbial Sensitivity Tests
  • Retrospective Studies
  • beta-Lactam Resistance*
  • beta-Lactamases / analysis
  • beta-Lactamases / metabolism*

Substances

  • Cephalosporins
  • beta-Lactamases